Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https://t.co/zeppnB7veD Refs: https://t.co/cPLN1x7WX2 https://t.co/a4PeyZBzvN @TheDoctorMack @LindenfeldJoann @ASE360 @escardio @NEJM @CMichaelGibson @iamritu https://t.co/j93JTQskvr
Transcatheter Mitral-Valve Repair in Patients with Heart Failure.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Dec 2018 – Jun 2025Where it's discussed
-
News153 articles
-
X / Twitter111 posts
-
Facebook15 posts
-
Blogs8 articles
-
YouTube3 videos
-
Reddit2 posts
AI synopsis
What people are saying
Numerous discussions emphasize specific results, such as the COAPT trial showing significant reductions in heart failure-related hospitalizations and overall mortality among those treated. Phrases like 'extraordinary results,' '40% reduction in death,' and 'sustained improvements' underscore the enthusiastic and impactful nature of the findings. The discussions’ tone, marked by positive language and specific references to clinical outcomes, illustrates a robust engagement with the material and a belief in its potential to influence medical practice.
Many discussions indicate support for the findings of the publication, highlighting positive outcomes associated with transcatheter mitral-valve repair.
There is a noticeable curiosity among posters, with many expressing an eagerness to explore more about the trial and results.
Several users delve deeply into specifics from the trials, referencing protocols, methodologies, and results, showcasing a high level of engagement.
The perceived impact is substantial, as users discuss the significance of the study in improving patient outcomes, suggesting that the findings could transform treatment approaches.
Abstract in brief
- Transcatheter mitral valve repair was studied in heart failure patients with significant mitral regurgitation, showing it might enhance clinical outcomes.
- In a trial with 614 patients, those receiving the repair along with medical therapy had fewer heart failure-related hospitalizations compared to those on medication alone.
- The procedure also led to a significantly lower risk of device-related complications and reduced overall mortality within 24 months.
Top posts
Most liked on X and BlueskyTranscatheter Mitral-Valve Repair in Patients with Heart Failure. https://t.co/sJDHP2dZcG @mjack2050
Proud to offer Mitraclip with an outstanding team @erlangerhealth that optimizes medications/CRT first & follows with shared decision making. 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure: https://t.co/aNFqLBnKXc #structuralheart @SCAI
Hi, this is my video for medical english, please be kind and leave your likes and comments!! Transcatheter Mitral Valve Repair in Patients with Heart Failure - Emily... https://t.co/jGkVVKxZtw via @YouTube
@GilbertTangMD @pomyers Here is the manuscript we wrote with Drs. @JonathanHongMD @tomcnguyen et al on #COAPT and #MITRAFR published in @annalsthorsurg. List of protocol changes were included in the @NEJM supplement #TSSMN: 1. COAPT - https://t.co/t2fvA7yg4q 2. MITRAFR - https://t.co/UyHkrsEuP5 https://t.co/rxtF7KgRwU
Beyond any doubt
All mentions
Mitral Valve Repair Improves Outcomes in Heart Failure Patients
Transcatheter mitral valve repair was studied in heart failure patients with significant mitral regurgitation. The procedure combined with medical therapy resulted in fewer hospitalizations and reduced overall mortality…
Key Cardiological Trials Impacting 2018 Outcomes
This video reviews the top 10 cardiology trials of 2018, highlighting significant studies including those on PCI strategies in cardiogenic shock and the effects of various treatments on cardiovascular outcomes. Discover…
Transcatheter Mitral Valve Repair and Cardiology Updates
The Café com Journal delivers updates on recent cardiology publications each week. This session discusses innovative studies, including the impact of transcatheter mitral valve repair in heart failure patients…
https://t.co/uApeAoN7vJ https://t.co/1Q1EeYK29M
Reshaping the Use of Transcatheter Mitral Valve Repair in Patients With Heart Failure: the RESHAPE-HF2 Trial - American College of Cardiology https://t.co/1T5anCHmHW
RT @KagiyamaNobu: なかなかFMRには良い治療がないなあ。。。となっていたところで、まさかのとんでもない治療効果を見せつけたのが2018年のCOAPT めちゃくちゃ開いたKM curveに、これはもうFMRの治療は = MitraClipだろ、という雰囲気が漂い…
なかなかFMRには良い治療がないなあ。。。となっていたところで、まさかのとんでもない治療効果を見せつけたのが2018年のCOAPT めちゃくちゃ開いたKM curveに、これはもうFMRの治療は = MitraClipだろ、という雰囲気が漂います ⬇️ https://t.co/EzF8W5NZkX https://t.co/jZvoZJWMoG
@RealAaronWiles @DanielCalhoun36 @BroadStBoss @JohnFetterman https://t.co/4wKYfNXDSE https://t.co/Yz2YRGdOfj https://t.co/GhXzMuj3wj with a seemingly niche use device, hard to get concrete answers on its medical usefulness. but for objectivity sake its not as clear cut as you think
RT @wordfinga: @ovidiogarciav @GreggWStone @rahatheart1 @rafasadaba @djc795 @FaisalBakaeen @VictorDayan1 @yreddyhf @RMSSAA @pomyers @JoeSab…
@ovidiogarciav @GreggWStone @rahatheart1 @rafasadaba @djc795 @FaisalBakaeen @VictorDayan1 @yreddyhf @RMSSAA @pomyers @JoeSabik @Migas2001 https://t.co/wC6iBM86gF Are there any other COAPT Trial papers by Stone et al, that cover in great detail, the control and device arms GDMT protocols?
RT @rafasadaba: @GreggWStone @VictorDayan1 @yreddyhf @djc795 @wordfinga @ovidiogarciav @RMSSAA @pomyers @FaisalBakaeen @JoeSabik @Migas2001…
RT @rafasadaba: @GreggWStone @VictorDayan1 @yreddyhf @djc795 @wordfinga @ovidiogarciav @RMSSAA @pomyers @FaisalBakaeen @JoeSabik @Migas2001…
RT @rafasadaba: @GreggWStone @VictorDayan1 @yreddyhf @djc795 @wordfinga @ovidiogarciav @RMSSAA @pomyers @FaisalBakaeen @JoeSabik @Migas2001…
RT @rafasadaba: @GreggWStone @VictorDayan1 @yreddyhf @djc795 @wordfinga @ovidiogarciav @RMSSAA @pomyers @FaisalBakaeen @JoeSabik @Migas2001…
@GreggWStone @VictorDayan1 @yreddyhf @djc795 @wordfinga @ovidiogarciav @RMSSAA @pomyers @FaisalBakaeen @JoeSabik @Migas2001 and BTW, the online NEJM paper takes you to version 1 of the protocol: https://t.co/58DezBTlXs
@GreggWStone @VictorDayan1 @yreddyhf @djc795 @wordfinga @ovidiogarciav @RMSSAA @pomyers @FaisalBakaeen @JoeSabik @Migas2001 It is true…”Subjects in this trial must have moderate-to-severe (3+) or severe (4+) functional mitral regurgitation and be likely to benefit from MR reduction, but are deemed too high risk to undergo mitral valve surgery”. It’s in your paper…https://t.co/am20Hgqh8C
RT @Ankyba: Transcatheter Mitral Valve Repair in Patients with Heart Failure https://t.co/BD0mQ1ZQ1Y a través de @YouTube @mjack2050
Transcatheter Mitral Valve Repair in Patients with Heart Failure https://t.co/BD0mQ1ZQ1Y a través de @YouTube @mjack2050
RT @DianaZapataGar2: Transcatheter Mitral-Valve Repair in Patients with Heart Failure Diana Zapata Garcia https://t.co/Bchc3j9e4r
Transcatheter Mitral-Valve Repair in Patients with Heart Failure Diana Zapata Garcia https://t.co/Bchc3j9e4r
RT @DianaZapataGar2: Transcatheter Mitral-Valve Repair in Patients with Heart Failure Diana Zapata https://t.co/zHUPPbHZRw
Transcatheter Mitral-Valve Repair in Patients with Heart Failure Diana Zapata https://t.co/zHUPPbHZRw
RT @TomShimoda: Is Mitra-clip a suitable option for functional mitral regurgitation? An interesting read. https://t.co/SNmEwsZ3OS
RT @plum_blaclaw: GDMTにより重症MRのうち40%は消失し, 予後改善が期待できるという論文の紹介も!(単施設研究) https://t.co/Aru4Y6vDSt COAPTはこちら https://t.co/THzzVVqcoe #22JCS
RT @plum_blaclaw: GDMTにより重症MRのうち40%は消失し, 予後改善が期待できるという論文の紹介も!(単施設研究) https://t.co/Aru4Y6vDSt COAPTはこちら https://t.co/THzzVVqcoe #22JCS
RT @plum_blaclaw: GDMTにより重症MRのうち40%は消失し, 予後改善が期待できるという論文の紹介も!(単施設研究) https://t.co/Aru4Y6vDSt COAPTはこちら https://t.co/THzzVVqcoe #22JCS
RT @plum_blaclaw: GDMTにより重症MRのうち40%は消失し, 予後改善が期待できるという論文の紹介も!(単施設研究) https://t.co/Aru4Y6vDSt COAPTはこちら https://t.co/THzzVVqcoe #22JCS
GDMTにより重症MRのうち40%は消失し, 予後改善が期待できるという論文の紹介も!(単施設研究) https://t.co/Aru4Y6vDSt COAPTはこちら https://t.co/THzzVVqcoe #22JCS
Is Mitra-clip a suitable option for functional mitral regurgitation? An interesting read. https://t.co/SNmEwsZ3OS
Age-Related Outcomes After Transcatheter Mitral Valve Repair in Patients With Heart Failure: Analysis From COAPT https://t.co/NRp6q8mBqq
Age-Related Outcomes After Transcatheter Mitral Valve Repair in Patients With Heart Failure: Analysis From COAPT - https://t.co/KmhC7qYdw9
Age-Related Outcomes After Transcatheter Mitral Valve Repair in Patients With Heart Failure: Analysis From COAPT - https://t.co/2HTUnd1nuQ
RT @iamritu: @ash71us @ASE360 @edwardagill @EGarciaSayan @CASEfromASE @JamesDThomasMD1 @ErinMichos @RigolinVera @VLSorrellImages @GWhalleyP…
RT @iamritu: @ash71us @ASE360 @edwardagill @EGarciaSayan @CASEfromASE @JamesDThomasMD1 @ErinMichos @RigolinVera @VLSorrellImages @GWhalleyP…
RT @iamritu: @ash71us @ASE360 @edwardagill @EGarciaSayan @CASEfromASE @JamesDThomasMD1 @ErinMichos @RigolinVera @VLSorrellImages @GWhalleyP…
RT @iamritu: @ash71us @ASE360 @edwardagill @EGarciaSayan @CASEfromASE @JamesDThomasMD1 @ErinMichos @RigolinVera @VLSorrellImages @GWhalleyP…
RT @iamritu: @ash71us @ASE360 @edwardagill @EGarciaSayan @CASEfromASE @JamesDThomasMD1 @ErinMichos @RigolinVera @VLSorrellImages @GWhalleyP…
@ash71us @ASE360 @edwardagill @EGarciaSayan @CASEfromASE @JamesDThomasMD1 @ErinMichos @RigolinVera @VLSorrellImages @GWhalleyPhD @DavidWienerMD @LucySafi @onco_cardiology @purviparwani @DocStrom @mswami001 In #Coapt volumetric calculations were thrown out because the LV volumes were significantly underestimated https://t.co/fYtDBLrl2k @JaeKOh2 @JamesDThomasMD1 #ASEchoJC https://t.co/Qx3RKgNl4K
Transcatheter Mitral-Valve Repair in Patients with Heart Failure https://t.co/3tr4j6au0P a través de @YouTube Hola amigos , me ayudarían dando un Like y comentando , es un Trabajo de la Universidad , de antemano Gracias .
Hi, this is my video for medical english, please be kind and leave your likes and comments!! Transcatheter Mitral Valve Repair in Patients with Heart Failure - Emily... https://t.co/jGkVVKxZtw via @YouTube
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure - ScienceDirect https://t.co/LDF8B5mx6k
RT @PracUpCardio: 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure https://t.co/qyNdNMCaF2 #cardiology
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure https://t.co/qyNdNMCaF2 #cardiology
RT @MCoylewright: Proud to offer Mitraclip with an outstanding team @erlangerhealth that optimizes medications/CRT first & follows with sha…
RT @MCoylewright: Proud to offer Mitraclip with an outstanding team @erlangerhealth that optimizes medications/CRT first & follows with sha…
RT @XavierPrida: Even delayed TMVr can save lives and improve QOL. Also, noteworthy 0 occurence of MS. 3-Year Outcomes of Transcatheter Mi…
RT @ArieBlitzMD: 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure confirm intermediate-term superiority…
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure: https://t.co/Xcix5PYJSw
RT @MCoylewright: Proud to offer Mitraclip with an outstanding team @erlangerhealth that optimizes medications/CRT first & follows with sha…
RT @MCoylewright: Proud to offer Mitraclip with an outstanding team @erlangerhealth that optimizes medications/CRT first & follows with sha…
Proud to offer Mitraclip with an outstanding team @erlangerhealth that optimizes medications/CRT first & follows with shared decision making. 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure: https://t.co/aNFqLBnKXc #structuralheart @SCAI
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
RT @hahn_rt: Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https:/…
Listen to @ACCinTouch Expert panel discussion “COAPT vs. MITRA-FR: Can we Define the Right Patient for Intervention?” https://t.co/zeppnB7veD Refs: https://t.co/cPLN1x7WX2 https://t.co/a4PeyZBzvN @TheDoctorMack @LindenfeldJoann @ASE360 @escardio @NEJM @CMichaelGibson @iamritu https://t.co/j93JTQskvr
Even delayed TMVr can save lives and improve QOL. Also, noteworthy 0 occurence of MS. 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure: https://t.co/OGuiCLWjK4
RT @PPibarot: In COPAT: TMVr had sustained 3-year improvements in HF hospitalization, MR severity, quality-of-life measures, and functiona…
RT @ArieBlitzMD: 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure confirm intermediate-term superiority…
RT @PPibarot: In COPAT: TMVr had sustained 3-year improvements in HF hospitalization, MR severity, quality-of-life measures, and functiona…
RT @RodrigoEstvez1: Beyond any doubt
RT @RodrigoEstvez1: Beyond any doubt
RT @PPibarot: In COPAT: TMVr had sustained 3-year improvements in HF hospitalization, MR severity, quality-of-life measures, and functiona…
RT @PPibarot: In COPAT: TMVr had sustained 3-year improvements in HF hospitalization, MR severity, quality-of-life measures, and functiona…
RT @PPibarot: In COPAT: TMVr had sustained 3-year improvements in HF hospitalization, MR severity, quality-of-life measures, and functiona…
Q Bueno ver q los resultados se mantienen a 3 años #MitraClip #HeartFailure #MitralRegurgitation 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure: https://t.co/28EPdF1TY4
Impressive results with #mitraclip. 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure: https://t.co/G6raGIWnc0
Beyond any doubt
RT @Shirley95516588: Transcatheter mitral-valve repair in patients with heart failure https://t.co/skGBuuUPeq
RT @Shirley95516588: Transcatheter mitral-valve repair in patients with heart failure https://t.co/skGBuuUPeq
Transcatheter mitral-valve repair in patients with heart failure https://t.co/skGBuuUPeq
Transcatheter mitral valve repair in patients with heart failure: A meta- analysis https://t.co/GixD25NHFJ
Transcatheter Mitral-Valve Repair in Patients with Heart Failure. https://t.co/sJDHP2dZcG @mjack2050
Although (surgical) repair can improve symptoms in secondary MR, no mortality benefit for Intervention vs OMT had been demonstrated until the 2018 COAPT RCT (29.1% to 46.1% at 2 years) via a transcatheter edge-to-edge repair for patients with HFrEF & sMR https://t.co/yEP2N2nlfG
Like y deja tu comentario :) @mjack2050 Transcatheter Mitral valve repair in patients with heart failure https://t.co/QKAZntNKHt via @YouTube
Mi percepción es que en Colombia obviamos por completo los resultados del COAPT Trial, ni siquiera el beneficio de la duda le dieron por la controversia con el MITRA FR, aunque las poblaciones fueron diferentes. Deberiamos esperar otros ensayos? https://t.co/OPKX7eyZh5
For some inspiration, consider Figure 1A in the NEJM COAPT paper (https://t.co/Jo9eKfPbRB) https://t.co/um5QpO1MQp
Dr. Ryan Kabir – Transcatheter Mitral-Valve Repair in Patients with Heart Failure https://t.co/iTurK95keD
RT @JessicaLuc1: @GilbertTangMD @pomyers Here is the manuscript we wrote with Drs. @JonathanHongMD @tomcnguyen et al on #COAPT and #MITRAFR…
RT @tUadxDWPm4I9Y6e: @WasedaChronicle https://t.co/qGOnOAHEPz 世界は新たな治療をもとめて進んでいるのですよ。こうやって日本の治療はどんどん遅れていくのです
RT @JessicaLuc1: @GilbertTangMD @pomyers Here is the manuscript we wrote with Drs. @JonathanHongMD @tomcnguyen et al on #COAPT and #MITRAFR…
RT @JessicaLuc1: @GilbertTangMD @pomyers Here is the manuscript we wrote with Drs. @JonathanHongMD @tomcnguyen et al on #COAPT and #MITRAFR…
RT @JessicaLuc1: @GilbertTangMD @pomyers Here is the manuscript we wrote with Drs. @JonathanHongMD @tomcnguyen et al on #COAPT and #MITRAFR…
RT @JessicaLuc1: @GilbertTangMD @pomyers Here is the manuscript we wrote with Drs. @JonathanHongMD @tomcnguyen et al on #COAPT and #MITRAFR…
RT @JessicaLuc1: @GilbertTangMD @pomyers Here is the manuscript we wrote with Drs. @JonathanHongMD @tomcnguyen et al on #COAPT and #MITRAFR…
RT @JessicaLuc1: @GilbertTangMD @pomyers Here is the manuscript we wrote with Drs. @JonathanHongMD @tomcnguyen et al on #COAPT and #MITRAFR…
@GilbertTangMD @pomyers Here is the manuscript we wrote with Drs. @JonathanHongMD @tomcnguyen et al on #COAPT and #MITRAFR published in @annalsthorsurg. List of protocol changes were included in the @NEJM supplement #TSSMN: 1. COAPT - https://t.co/t2fvA7yg4q 2. MITRAFR - https://t.co/UyHkrsEuP5 https://t.co/rxtF7KgRwU
@venkmurthy @FZores RAS blocker use is at baseline. Beta-blocker use is at 1 year (at baseline, 91.1% vs. 89.7%). https://t.co/AP4YySkUFQ (Table S6) 1/
#HFSA2019: See how Transcatheter mitral-valve repair may improve clinical outcomes for #HeartFailure patients.
RT @SeeFisch: Transcatheter Mitral-Valve Repair in Patients with Heart Failure | NEJM https://t.co/nVoeljOjBN
RT @SeeFisch: Transcatheter Mitral-Valve Repair in Patients with Heart Failure | NEJM https://t.co/nVoeljOjBN
RT @SeeFisch: Transcatheter Mitral-Valve Repair in Patients with Heart Failure | NEJM https://t.co/nVoeljOjBN
Transcatheter Mitral-Valve Repair in Patients with Heart Failure | NEJM https://t.co/nVoeljOjBN
RT @NEJM: Original Article: Transcatheter Mitral-Valve Repair in Patients with Heart Failure https://t.co/eX7FV4wvfk Editorial: Percutaneo…
RT @hmkyale: COAPT trial results are extraordinary. 40% reduction in death. 50% for HF hospitalizations. Entry criteria: symptomatic HF w/s…
Dr. Arnold discussing the COAPT Trial QoL data: Quality of Life After Transcatheter Mitral-Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation. Happening now in the Main Tent! #ACC19 #COAPT
10 #COAPT: Mitral Regurgitation After MitraClip Implantation in Patients with Heart Failure & 2nd Mitral Regurgitation: Echo Outcomes from COAPT 11 QOL After Transcatheter Mitral-Valve Repair in Patients with Heart Failure & 2nd Mitral Regurgitation: from #COAPT @GreggWStone
@NirUrielMD @DrRoderickTung @tscherian @gauravaupadhyay @robertomlang Dr. Nathan @SandeepNathanMD comprehensively presenting on management of MR in HF. recent decision pathway: https://t.co/b0q9TxLFgT COAPT trial: https://t.co/I7TYevWNxc #UCHF19
Treatment with MitraClip plus medical therapy resulted in a statistically significant reduction in HF hospitalization through two years compared to medical therapy alone (annualized rate of 67.9% per year vs. 35.8% per year; p<0.001). https://t.co/sHg5OC3IKJ https://t.co/0MfhdIirtj
COAPT Trial Transcatheter Mitral-Valve Repair in Patients with Heart Failure https://t.co/xRCiHu21ef https://t.co/hOCx9Gv4NP
RT @jade_marrow96: N Engl J Med study shows transcatheter mitral-valve repair resulted in lower rates of hospitalization for HF and reduced…
N Engl J Med study shows transcatheter mitral-valve repair resulted in lower rates of hospitalization for HF and reduced all-cause mortality within 2y of follow-up: https://t.co/eoOo01VPM7 #biom4180
RT @ClevClinicHeart: Cardiac Consult Podcast: Transcatheter Mitral Valve Repair in Patients with Heart Failure: Do the results of the COAPT…
Cardiac Consult Podcast: Transcatheter Mitral Valve Repair in Patients with Heart Failure: Do the results of the COAPT trial impact care? https://t.co/IbjbJo5Wg0
By contrast #COAPT showed that 2 yrs after getting a MitraClip patients had lower rates of hospitalization for heart failure and lower all-cause mortality than drug treatment alone. https://t.co/buvLGROgK0 https://t.co/OyKVOGbJQj